NEWS: "Hot Off the Press"
- UPDATED -- ZenaTech Develops Low-Cost, Single-Use Autonomous Interceptor Drone for ZenaDrone’s Counter-UAS System for US Defense, Middle East, and Ukraine Use
- RMX Industries, Inc. Announces Confidential Submission of Draft S-1 Registration Statement to the U.S. Securities and Exchange Commission
- VisionWave Subsidiary SolarDrone Acquires Controlling Interest in Junko Solar and Appoints Industry Executive as CEO
- ZenaTech Develops Low-Cost, Single-Use Autonomous Interceptor Drone for ZenaDrone’s Counter-UAS System for US Defense, Middle East, and Ukraine Use
- 1606 Corp. Signs Agreement to Acquire Data-Center-Ready Property with Captive Power on 132 Acres
- AXIL Brands Unveils New Monster Jam® Series Earplugs: X20i and X30i Models Featuring Iconic Truck Designs
- Cycurion, Inc. Statement Regarding Unauthorized Press Release, Fabrication of Investor Relations Contact, and Related Market Activity – Litigation Counsel Engaged to Address Short Selling and Manipulation
- NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application
- VisionWave Aligns With Largest Creditor of C.M., Advancing Planned Acquisition of Israeli Defense Manufacturing Platform
- Wearable Devices Strengthens AI Advisory Board with Former Google and Qualcomm Executives to Accelerate ai6 Labs’ Vision
- VisionWave Aligns With Largest Creditor of C.M., Advancing Planned Acquisition of Israeli Defense Manufacturing Platform
- Off The Hook to Participate in the 38th Annual ROTH Conference
- Millions Locked Out of Banking May Soon Find an Alternative at the Checkout Line. Alpha Cash Plans to Be That Alternative
- Cycurion (Nasdaq: CYCU) Announces Definitive Agreement to Acquire Federal Cybersecurity Firm and Reports Record Contracted Backlog Exceeding $150 Million
- NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting
